Clinical features and treatment outcomes of Hodgkin’s lymphoma in Hong Kong Chinese

Abstract

IntroductionLittle information is available on the outcomes of Hodgkin's lymphoma in Chinese patients. We analyzed the clinical and histopathological characteristics, treatment types, clinical course and treatment outcomes of Hong Kong Chinese patients.Material and methodsPatients with Hodgkin's lymphoma diagnosed from January 1991 to December 2010 were recruited. A retrospective analysis of these patients was performed.ResultsSixty-seven Chinese patients (38 males and 29 females) were identified and the median age was 36 (range 16–80). Nodular sclerosis was the most common histology (54%), followed by mixed cellularity (36%). Twenty-four patients had early favorable, 20 patients had early unfavorable and 23 patients had advanced-stage diseases. The most common presentation was palpable lymph node or mass (85%) followed by fever, weight loss, night sweating and mediastinal mass. Ninety percent of patients received chemotherapy and 40% received radiotherapy as consolidation. Seven patients with stage I lymphoma received radiotherapy alone. ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine) was the most commonly used chemotherapeutic regimen. Following treatment, 87% of patients achieved complete remission. Six patients relapsed after first remission and 3 achieved second remission after re-induction therapy. The 5-year overall survival of the entire cohort was 89% and the freedom from treatment failure (FFTF) at 5 years was 82%. The 5-year overall survival rate for early favorable, early unfavorable and advanced stages was 95.7%, 95.0% and 74.7%, respectively.ConclusionsDespite the relatively low incidence of Hodgkin's lymphoma in Hong Kong Chinese, the treatment outcomes are comparable to Caucasian patients.

Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital

“…A bimodal age-specific incidence pattern, with a relatively high proportion of cases in adolescents and young adults, is commonly observed in Western industrialized countries [2]. However, we observed an early peak in young adults without a bimodal age distribution in our cohort and similar findings were also reported among Hong Kong Chinese patients diagnosed with HL [12]. Nodular sclerosis was the most common histological subtype found in our patients followed by mixed cellularity.…”

Clinical Features and Prognosis Analysis of Hodgkin Lymphoma: A Multicenter Retrospective Study Over a Decade of Patients in China

“…① Geographic and ethnic factors: According to a report from June-Won Cheong et al [14] , the findings for 105 HL patients (regardless of the disease stage) were as follows: 5-year DFS, 79.2%; 5-year OS, 84.8%; and ORR, 87.6%. Similar results were also reported in a retrospective study involving 67 Chinese patients in Hong Kong [21] , which showed a 5-year OS of 89% for all patients, 74.7% for patients with advanced-stage HL and 95% for patients with early-stage HL. All of these figures were lower than those reported for the Caucasian patients, but similar to the results obtained in our study.…”

Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya

“…Given the high prevalence of tuberculosis in Low income settings, most of these patients are likely to be treated with antituberculosis medication and an alternative diagnosis is only sought when there is no response several months later. [25][26] However, our median patient and physician delays for Hodgkin lymphoma patients were not extremely long compared to other types of cancers.…”